Cargando…
Study of beta-cell function (by HOMA model) in metabolic syndrome
INTRODUCTION: The clustering of cardiovascular risk factors is termed the metabolic syndrome (MS), which strongly predict risk of diabetes and cardiovascular disease. Many studies implicate insulin resistance (IR) in the development of diabetes, but ignore the contribution of beta-cell dysfunction....
Autores principales: | Garg, M. K., Dutta, M. K., Mahalle, Namita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3152191/ https://www.ncbi.nlm.nih.gov/pubmed/21847454 http://dx.doi.org/10.4103/2230-8210.83059 |
Ejemplares similares
-
Adipokines (adiponectin and plasminogen activator inhhibitor-1) in metabolic syndrome
por: Garg, M. K., et al.
Publicado: (2012) -
Association of metabolic syndrome with severity of coronary artery disease
por: Mahalle, Namita, et al.
Publicado: (2014) -
The HOMA-Adiponectin (HOMA-AD) Closely Mirrors the HOMA-IR Index in the Screening of Insulin Resistance in the Brazilian Metabolic Syndrome Study (BRAMS)
por: Vilela, Brunna Sullara, et al.
Publicado: (2016) -
Calcium Supplementation: Why, Which, and How?
por: Garg, M. K., et al.
Publicado: (2019) -
Study of pattern of dyslipidemia and its correlation with cardiovascular risk factors in patients with proven coronary artery disease
por: Mahalle, Namita, et al.
Publicado: (2014)